See the Glossary for more terms.
NIH and NIAID are on the lookout for people who try to send additional data to get around page limits or content requirements.
NIH set new rules on submitting material that you didn't put in your application but want to include before the peer review meeting.
If you're sending information on an application form—for example, an additional biosketch or missing budget page—be sure to follow the page limits and application instructions, just like you would have if you'd included it in the first place.
However, if you're sending additional material that's not required on a form page, keep within the page limits below:
Consider the following before sending post-submission information:
We must receive additional materials 30 calendar days before the peer review meeting. For more information, read the March 19, 2010, Guide notice.
If you are applying for a request for applications or institute-specific program announcement, such as a PAR, always check the funding opportunity announcement because procedures and timing may be different.
To learn about what application materials you can submit after the deadline and how to send them in, go to NIH Best Practice Guidelines (MS WORD) and If You Need to Send Revised Information in the Strategy for NIH Funding.
Leadership changes are afoot at the Immune Tolerance Network (ITN).
Dr. Gerald Nepom has replaced founder and departing director Dr. Jeffrey Bluestone, and Deputy Director Dr. Laurence Turka has seen his role expanded.
Cosponsored by NIAID's Division of Allergy, Immunology, and Transplantation (DAIT) and the Juvenile Diabetes Research Foundation International (JDRF), ITN is a consortium of more than 80 investigators committed to finding new tolerance induction strategies for patients with allergies, organ transplants, or autoimmune diseases.
Familiar Faces in New Positions
In his new role, Dr. Nepom will chair the steering and executive committees and lead ITN's scientific agenda.
As a member of the initial steering committee, Dr. Nepom is already familiar with the network. In his new role, he will lead ITN's scientific agenda and chair its steering and executive committees.
"We are very excited to be working with Jerry in his new role," says DAIT Director Dr. Daniel Rotrosen. "His scientific expertise and leadership skills will be tremendous assets in guiding the consortium to further progress and success."
Dr. Nepom is an internationally recognized researcher in autoimmunity, with a focus on type 1 diabetes, rheumatoid arthritis, and multiple sclerosis. He serves on many editorial and professional advisory boards, and is immediate past president of the Federation of Clinical Immunology Societies, an organization dedicated to interdisciplinary research and education in translational immunology.
Currently, Dr. Nepom is director of the Benaroya Research Institute at Virginia Mason (BRI) and affiliate professor in the Department of Immunology at the University of Washington School of Medicine. To see his bio, go to Gerald T. Nepom, MD, PhD on BRI's Web site.
As Dr. Nepom begins his tenure, he will benefit from the guidance and insight of Dr. Turka, another ITN veteran who has been with the network since its inception. In an expansion of his role as deputy director for Tolerance Assays and Data Analysis, Dr. Turka will also oversee strategic planning, coordination, and implementation of mechanistic study activities.
In an expansion of his role as deputy director, Dr. Turka will oversee strategic planning, coordination, and implementation of mechanistic study activities.
To learn more about Dr. Turka, see his ITN profile and read the September 8, 2009, Press Release from Beth Israel Deaconess Medical Center, where he joined the faculty last year.
Thank You, Dr. Bluestone
While NIAID welcomes Dr. Nepom, we also want to acknowledge the dedication and leadership of Dr. Bluestone, his predecessor.
Dr. Rotrosen recently wrote, "From its inception a decade ago, Jeff has led the ITN with dedication and an extraordinary vision. That vision is evident in the growth and evolution of the ITN, its many achievements, and its interface with NIAID and the immunology research community."
We wish Dr. Bluestone well as he begins his new position as executive vice chancellor and provost at the University of California, San Francisco. For more on this, read UCSF's March 25, 2010, News Release.
Though its leadership is changing, ITN's mission remains the same.
Though its leadership is changing, ITN's mission remains the same: to conduct clinical trials with associated mechanistic studies of specialized immune tolerance therapies.
The network will continue to rely on researchers for ideas and applications for novel clinical trials.
For an idea of active and completed clinical trials, go to ITN's Clinical Trials. Projects span the spectrum from Promoting Tolerance to Peanut in High-Risk Children to Immunosuppression Withdrawal for Pediatric Living-Donor Liver Transplant Recipients.
For more information and resources, go to ITN's Welcome page.
If you want the raw data from CRISP, grab a copy by June 30.
Still using raw data files from CRISP? Be aware that this file format is going away. June 30, 2010, will be your last chance to download the CRISP Legacy Data.
Since RePORT is up and running, you can start using raw data from ExPORTER instead.
The ExPORTER Data Catalog goes back to 2005 so far. NIH data managers plan to add more historical data later, though we don't know how far back it will eventually go.
We last wrote about ExPORTER in our February 17, 2010, article "Check Out Updated RCDC Report Data."
If you had trouble entering your data into FederalReporting.gov in time for the April deadline, you have a reprieve: the reporting period deadline has been extended through Friday, April 16, 2010.
Because of this extension, you will have from April 17 to April 19 to review your data. Go to FederalReporting.gov for news, tips, help, and the reporting timeline.
When NIH set its award levels for tuition, fees, and health insurance on training and fellowship grants, it said it would revisit the calculation at a later date.
NIH sent word that it will stick with its formula. Read details in the March 24, 2010, Guide notice.
For more, go to Applying for a Fellowship and Institutional Research Training Grants in our Advice on Research Training and Career Awards.
Whenever you have an exciting discovery that you're ready to publish, make sure NIAID's Office of Communications and Government Relations knows about it.
Contact your program officer as soon as your article is accepted for publication.
Our staff can prepare news releases and coordinate media inquiries to improve coverage from major news outlets and national publications.
Contact your program officer as soon as your article is accepted for publication, so we can determine how to best highlight your findings and field questions from the press. Read more in our Requesting NIAID's Help on Publicizing Research Advances SOP.
Find lists of open positions and upcoming conferences and career fairs NIAID will attend.
If you are looking for a career with NIAID—whether you want to do research, management, or administration—go to Careers at NIAID.
The site has tips about applying and information about working for us, including lists of Open Scientific Positions, Open Business Management Positions, and Upcoming Conferences and career fairs NIAID will attend.
Other items from the menu:
Bookmark this page and check it regularly, as NIAID plans to add more information about careers and benefits in the coming months.
You can also get weekly tweets on NIAID career opportunities through NIAID's Twitter feed, @NIAIDNews. Read more about NIAID's foray into Twitter in our March 3, 2010, article "Follow Us on Twitter."
Looking for training and research experiences at NIAID? We have information for you, too. Read the next article, "Get In On Intramural Research and Training Opportunities, Too."
If you seek training or research experience, here's a tip to point you in the right DIRection: NIAID's Division of Intramural Research. Whether you're an M.D., Ph.D., postdoc, or student, DIR has opportunities here at NIAID that may suit your needs.
DIR has postdoctoral positions to help you explore the research you want to pursue.
If you have a Ph.D. under your belt and want some time doing benchwork, DIR has postdoctoral positions to help you explore the research you want to pursue. For an overview, go to Training in NIAID Labs.
To find out about current openings, see Postdoctoral Fellowship Program.
Students interested in careers in biomedical research can take advantage of these training and educational opportunities:
For questions about either program, contact NIAID's Office of Training and Diversity.
Paging All Physicians
For M.D.s, DIR offers clinical fellowship programs that combine clinical training with basic or translational research, described below.
Starting With the Basics
Physicians can develop their clinical and basic research skills in either infectious diseases or allergy and immunology.
With DIR training programs, physicians can develop their clinical and basic research skills in either infectious diseases or allergy and immunology.
Qualified candidates may receive help paying off eligible educational debt through NIH's Loan Repayment Programs.
Approved by the Accreditation Council for Graduate Medical Education, each three-year program provides trainees one year of clinical duties and two years of research. See the following for more information, including details on training structure and the application process:
Transitioning to Translational
DIR also has a program that lets physicians gain clinical and translational experience in NIAID labs. Participants receive salary, staff, and resources, and are paired with a senior clinical investigator who serves as a mentor.
For details, go to Transition Program in Clinical Research. See the list of NIAID labs at DIR Laboratories.
Get More Information
Go to The NIAID Training Experience to learn more about the benefits of training and research at NIAID, and find helpful links to the programs listed above and other resources at Training in NIAID Labs.
Workshop on HIV—Exposed and Resistant is July 8 and 9 in Gaithersburg, MD.
NIAID's Division of AIDS wants to get to the bottom of an intriguing question: how do some people exposed to HIV remain uninfected?
To start finding answers, DAIDS is hosting the Workshop on HIV—Exposed and Resistant meeting on this important topic on July 8 and 9 in Gaithersburg, MD. Mark it down now before your calendar fills up.
The session is a follow-on of last November's International Symposium on Natural Immunity to HIV and covers a lot of ground, including:
To get more details and register, go to Workshop on HIV—Exposed and Resistant next week for more information.
An inadequate, incomplete, or missing plan can derail your hopes for funding.
Don't underestimate the importance of the Vertebrate Animal Section of the application if you plan research involving live vertebrate animals.
An inadequate plan for animals may hurt your overall impact score, and an incomplete or missing plan could exclude your application from review.
NIH revised the Worksheet for Review of the Vertebrate Animal Section (PDF) to better explain the five points you should address in your plan.
The March 17, 2010, Guide notice also spells out roles for the applicant, study section, NIH staff, and IACUC.
We've revised Answer the Five Points in the Vertebrate Animals Section in our How to Write an Application Involving Research Animals guide to reflect the new details. The tutorial also covers topics such as considering alternatives to using animals, getting an animal welfare assurance, and working with your IACUC.
We first wrote about the Worksheet in our December 23, 2009, article "Your Vertebrate Animal Plan Step by Step."
Feel free to send us a question at firstname.lastname@example.org. After responding to you, we may include your question in the newsletter, incorporate it into the NIAID Research Funding site, or both.
If NIAID is not listed under "Components of Participating Organizations" in a funding opportunity announcement, we do not support it. For another way to learn if we participate in a FOA, go to NIAID Funding Opportunities List.
That said, our not participating in a FOA doesn't mean we don't support a similar area of research. To determine if that's the case, check with a program officer or, if you want to discuss training and career awards, our Office of Special Populations and Research Training.
To find a program officer and learn more about what he or she does, go to Contact Staff for Help in the Strategy for NIH Funding. To contact OSPRT, email AITrainingHelpDesk@niaid.nih.gov.
When considering applying under an initiative, it's always a good idea to talk to the program officer to get an idea of the competition and how well your expertise fits the science area.
We send out email alerts when NIH releases new funding opportunities relevant to NIAID. To receive email alerts, subscribe at NIAID Funding Newsletter and Email Alerts Subscription Center.
We post new opportunities on NIAID Funding Opportunities List and Latest Funding Updates as soon as they are published in the NIH Guide.
To find out if an opportunity will be reissued, contact the program officer listed in the announcement.
You can also go to Concepts: Potential Opportunities for a heads-up on what potential initiatives are coming. If you haven't used that resource before, you might also find it helpful to read our March 17, 2010, Funding Newsletter article "Latest Concepts—Preview Our High-Priority Areas."
As for being notified of when an announcement comes out, subscribe to email alerts, as we describe in question #1.
We generally do not have a separate area for posting detailed information, although for particularly complex opportunities we may.
On NIAID Funding Opportunities List, we do provide links to funding opportunity announcements, which have contact information for program officers who can tell you more about their initiatives.
See these and older announcements at NIAID Funding Opportunities List.
back to top
Last Updated October 06, 2011
Last Reviewed April 14, 2010